XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
172 hedge funds and large institutions have $1.9B invested in Acceleron Pharma in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 58 increasing their positions, 62 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
6% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 62
33% less call options, than puts
Call options by funds: $5.12M | Put options by funds: $7.66M
Holders
172
Holding in Top 10
4
Calls
$5.12M
Puts
$7.66M
Top Buyers
| 1 | +$18.7M | |
| 2 | +$10.3M | |
| 3 | +$10M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$6.7M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$6.61M |
Top Sellers
| 1 | -$28.7M | |
| 2 | -$19.7M | |
| 3 | -$14.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.85M |
| 5 |
Two Sigma Investments
New York
|
-$4.85M |